Date Name Title Filing Type Shares Traded Price Total Held
Jan 09, 2006
Director
Director Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 10,000 -- --
Jan 09, 2006
Director
Director Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 10,000 -- --
Jan 09, 2006
Director
Director Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 10,000 -- --
Jan 09, 2006
SVP, PreclinDevel & Biomol Sci
SVP, PreclinDevel & Biomol Sci Form 4 Open market or private sale of non-derivative or derivative security 15 $16.89 4,856
Jan 09, 2006
SVP, PreclinDevel & Biomol Sci
SVP, PreclinDevel & Biomol Sci Form 4 Open market or private sale of non-derivative or derivative security 17 $16.88 4,839
Jan 09, 2006
SVP, PreclinDevel & Biomol Sci
SVP, PreclinDevel & Biomol Sci Form 4 Open market or private sale of non-derivative or derivative security 57 $16.91 4,782
Jan 09, 2006
SVP, PreclinDevel & Biomol Sci
SVP, PreclinDevel & Biomol Sci Form 4 Open market or private sale of non-derivative or derivative security 65 $16.92 4,717
Jan 09, 2006
SVP, PreclinDevel & Biomol Sci
SVP, PreclinDevel & Biomol Sci Form 4 Open market or private sale of non-derivative or derivative security 57 $16.98 4,660
Jan 09, 2006
SVP, PreclinDevel & Biomol Sci
SVP, PreclinDevel & Biomol Sci Form 4 Open market or private sale of non-derivative or derivative security 144 $16.99 4,516
Jan 09, 2006
SVP, PreclinDevel & Biomol Sci
SVP, PreclinDevel & Biomol Sci Form 4 Open market or private sale of non-derivative or derivative security 22 $17.00 4,494

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.